Wegovy FlexTouch Injection (Semaglutide)
Wegovy FlexTouch Injection (Semaglutide) is a prescription GLP-1 receptor agonist used for chronic weight management in adults with obesity or overweight conditions. It works by reducing appetite, increasing the feeling of fullness, and helping control food intake. When combined with a healthy diet and regular exercise, it supports effective and gradual weight loss under medical supervision.
Introduction of Wegovy FlexTouch Injection (Semaglutide)
Wegovy FlexTouch Injection contains Semaglutide, a clinically proven GLP-1 receptor agonist developed for chronic weight management. It is specifically prescribed for adults who are obese or overweight and have at least one weight-related medical condition such as hypertension, type 2 diabetes, or dyslipidemia.
This medicine works by targeting appetite regulation centers in the brain, helping individuals feel fuller for longer periods and reducing overall food intake. It is most effective when combined with a reduced-calorie diet and increased physical activity.
Precautions of Wegovy FlexTouch Injection (Semaglutide)
- Use only under medical supervision
- Not recommended for type 1 diabetes patients
- Inform your doctor if you have thyroid, kidney, or pancreatic issues
- Avoid alcohol consumption
- Not suitable for pregnant or breastfeeding women without doctor advice
- Follow proper dosage schedule strictly
Uses of Wegovy FlexTouch Injection (Semaglutide)
- Chronic weight management in adults
- Treatment of obesity
- Management of overweight individuals with related conditions (such as high blood pressure, diabetes, or cholesterol)
- Appetite control
- Supporting lifestyle-based weight loss programs
- Reducing risk factors associated with obesity
Side Effects of Wegovy FlexTouch Injection (Semaglutide)
Common side effects may include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Loss of appetite
- Abdominal pain
- Headache
- Fatigue
- Dizziness
Serious but rare side effects:
- Pancreatitis
- Gallbladder problems
- Severe allergic reactions
- Thyroid tumors (very rare risk)
| Manufacturer | : | Novo Nordisk India Pvt Ltd |
| Equivalent Brand | : | Ozempic |
| Generic Search | : | Semaglutide |
